Comparison of Amiodarone and Propafenone in Blanking Period after Radiofrequency Catheter Ablation in Patients with Atrial Fibrillation: A Propensity Score-Matched Study
Table 3
Univariate analysis of ER.
Variable
ER+
ER-
General information
Age, years
0.122
Sex, M/F
59/39
117/55
0.195
BMI, kg/m2
0.424
AF type
PAF/PeAF
87/11
151/21
0.810
Medical history
AFL
10 (10.2)
18 (10.5)
0.946
AT
12 (12.2)
19 (11.0)
0.766
HT
54 (55.1)
87 (50.6)
0.475
HHD
26 (26.5)
50 (29.1)
0.656
CAD
17 (17.3)
21 (12.2)
0.243
DM
1 (1.0)
6 (3.5)
0.220
VHD
19 (19.4)
18 (10.5)
0.040
GUCH
3 (3.1)
6 (3.5)
0.851
Diabetes
16 (16.3)
28 (16.2)
0.992
Stoke/TIA
2 (2.1)
7 (4.1)
0.220
PVD
2 (2.1)
4 (2.3)
0.879
HLP
32 (32.7)
52 (30.3)
0.684
HUA
17 (17.3)
42 (24.4)
0.176
Laboratory test results
TC, mmol/L
0.422
LDL-C, mmol/L
0.425
NT-proBNP, ng/L
0.390
CR, umol/L
0.845
Echocardiogram parameters
LAD, mm
37.02 ± 6.41
35.15 ± 6.03
0.019
LVEF, %
67.72 ± 7.49
65.50 ± 6.85
0.026
CHA2DS2VASc
2.01 ± 1.39
1.86 ± 1.55
0.430
Medication use after RFCA
β-Blockers
13 (13.3)
30 (17.4)
0.367
ACEI/ARB
43 (43.8)
52 (30.2)
0.024
Statins
32 (32.7)
54 (31.4)
0.831
Amiodarone
32 (32.7)
103 (59.8)
<0.001
Variables associated with ER statistically (). Values are , / or (%).
